
|Articles|June 1, 2004
Drug treatment has mixed success in preventing progression of AKs
Determining risk of progression is key in deciding chemopreventive therapy
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Clascoterone 5% Delivers Strong Phase 3 Hair-Growth Results
2
Top 5 Articles of the Week: November 30-December 5
3
The Weekly Roundup: December 1-5
4
Nearly Half of Female Psoriasis Patients Report IPV, Study Finds
5



















